Global Psychiatric Medications Market 2023 by Company, Regions, Type and Application, Forecast to 2029

1 Market Overview

• 1.1 Product Overview and Scope of Psychiatric Medications
• 1.2 Market Estimation Caveats and Base Year
• 1.3 Classification of Psychiatric Medications by Type
  • 1.3.1 Overview: Global Psychiatric Medications Market Size by Type: 2018 Versus 2022 Versus 2029
  • 1.3.2 Global Psychiatric Medications Consumption Value Market Share by Type in 2022
  • 1.3.3 Antidepressants
  • 1.3.4 Anti-anxiety Medications
  • 1.3.5 Mood-stabilizing Medications
  • 1.3.6 Antipsychotic Medications
• 1.4 Global Psychiatric Medications Market by Application
  • 1.4.1 Overview: Global Psychiatric Medications Market Size by Application: 2018 Versus 2022 Versus 2029
  • 1.4.2 Hospital Use
  • 1.4.3 Clinic Use
  • 1.4.4 Household
• 1.5 Global Psychiatric Medications Market Size & Forecast
• 1.6 Global Psychiatric Medications Market Size and Forecast by Region
  • 1.6.1 Global Psychiatric Medications Market Size by Region: 2018 VS 2022 VS 2029
  • 1.6.2 Global Psychiatric Medications Market Size by Region, (2018-2029)
  • 1.6.3 North America Psychiatric Medications Market Size and Prospect (2018-2029)
  • 1.6.4 Europe Psychiatric Medications Market Size and Prospect (2018-2029)
  • 1.6.5 Asia-Pacific Psychiatric Medications Market Size and Prospect (2018-2029)
  • 1.6.6 South America Psychiatric Medications Market Size and Prospect (2018-2029)
  • 1.6.7 Middle East and Africa Psychiatric Medications Market Size and Prospect (2018-2029)

2 Company Profiles

• 2.1 Pfizer
  • 2.1.1 Pfizer Details
  • 2.1.2 Pfizer Major Business
  • 2.1.3 Pfizer Psychiatric Medications Product and Solutions
  • 2.1.4 Pfizer Psychiatric Medications Revenue, Gross Margin and Market Share (2018-2023)
  • 2.1.5 Pfizer Recent Developments and Future Plans
• 2.2 AstraZeneca
  • 2.2.1 AstraZeneca Details
  • 2.2.2 AstraZeneca Major Business
  • 2.2.3 AstraZeneca Psychiatric Medications Product and Solutions
  • 2.2.4 AstraZeneca Psychiatric Medications Revenue, Gross Margin and Market Share (2018-2023)
  • 2.2.5 AstraZeneca Recent Developments and Future Plans
• 2.3 Eli Lilly and Company
  • 2.3.1 Eli Lilly and Company Details
  • 2.3.2 Eli Lilly and Company Major Business
  • 2.3.3 Eli Lilly and Company Psychiatric Medications Product and Solutions
  • 2.3.4 Eli Lilly and Company Psychiatric Medications Revenue, Gross Margin and Market Share (2018-2023)
  • 2.3.5 Eli Lilly and Company Recent Developments and Future Plans
• 2.4 GlaxoSmithKline
  • 2.4.1 GlaxoSmithKline Details
  • 2.4.2 GlaxoSmithKline Major Business
  • 2.4.3 GlaxoSmithKline Psychiatric Medications Product and Solutions
  • 2.4.4 GlaxoSmithKline Psychiatric Medications Revenue, Gross Margin and Market Share (2018-2023)
  • 2.4.5 GlaxoSmithKline Recent Developments and Future Plans
• 2.5 Johnson & Johnson
  • 2.5.1 Johnson & Johnson Details
  • 2.5.2 Johnson & Johnson Major Business
  • 2.5.3 Johnson & Johnson Psychiatric Medications Product and Solutions
  • 2.5.4 Johnson & Johnson Psychiatric Medications Revenue, Gross Margin and Market Share (2018-2023)
  • 2.5.5 Johnson & Johnson Recent Developments and Future Plans
• 2.6 Novartis
  • 2.6.1 Novartis Details
  • 2.6.2 Novartis Major Business
  • 2.6.3 Novartis Psychiatric Medications Product and Solutions
  • 2.6.4 Novartis Psychiatric Medications Revenue, Gross Margin and Market Share (2018-2023)
  • 2.6.5 Novartis Recent Developments and Future Plans
• 2.7 H. Lundbeck
  • 2.7.1 H. Lundbeck Details
  • 2.7.2 H. Lundbeck Major Business
  • 2.7.3 H. Lundbeck Psychiatric Medications Product and Solutions
  • 2.7.4 H. Lundbeck Psychiatric Medications Revenue, Gross Margin and Market Share (2018-2023)
  • 2.7.5 H. Lundbeck Recent Developments and Future Plans
• 2.8 Abbott Laboratories
  • 2.8.1 Abbott Laboratories Details
  • 2.8.2 Abbott Laboratories Major Business
  • 2.8.3 Abbott Laboratories Psychiatric Medications Product and Solutions
  • 2.8.4 Abbott Laboratories Psychiatric Medications Revenue, Gross Margin and Market Share (2018-2023)
  • 2.8.5 Abbott Laboratories Recent Developments and Future Plans
• 2.9 Otsuka Pharmaceutical
  • 2.9.1 Otsuka Pharmaceutical Details
  • 2.9.2 Otsuka Pharmaceutical Major Business
  • 2.9.3 Otsuka Pharmaceutical Psychiatric Medications Product and Solutions
  • 2.9.4 Otsuka Pharmaceutical Psychiatric Medications Revenue, Gross Margin and Market Share (2018-2023)
  • 2.9.5 Otsuka Pharmaceutical Recent Developments and Future Plans
• 2.10 Gedeon Richter
  • 2.10.1 Gedeon Richter Details
  • 2.10.2 Gedeon Richter Major Business
  • 2.10.3 Gedeon Richter Psychiatric Medications Product and Solutions
  • 2.10.4 Gedeon Richter Psychiatric Medications Revenue, Gross Margin and Market Share (2018-2023)
  • 2.10.5 Gedeon Richter Recent Developments and Future Plans
• 2.11 Lupin Pharmaceuticals
  • 2.11.1 Lupin Pharmaceuticals Details
  • 2.11.2 Lupin Pharmaceuticals Major Business
  • 2.11.3 Lupin Pharmaceuticals Psychiatric Medications Product and Solutions
  • 2.11.4 Lupin Pharmaceuticals Psychiatric Medications Revenue, Gross Margin and Market Share (2018-2023)
  • 2.11.5 Lupin Pharmaceuticals Recent Developments and Future Plans
• 2.12 Luye Pharma
  • 2.12.1 Luye Pharma Details
  • 2.12.2 Luye Pharma Major Business
  • 2.12.3 Luye Pharma Psychiatric Medications Product and Solutions
  • 2.12.4 Luye Pharma Psychiatric Medications Revenue, Gross Margin and Market Share (2018-2023)
  • 2.12.5 Luye Pharma Recent Developments and Future Plans
• 2.13 SK Biopharmaceuticals
  • 2.13.1 SK Biopharmaceuticals Details
  • 2.13.2 SK Biopharmaceuticals Major Business
  • 2.13.3 SK Biopharmaceuticals Psychiatric Medications Product and Solutions
  • 2.13.4 SK Biopharmaceuticals Psychiatric Medications Revenue, Gross Margin and Market Share (2018-2023)
  • 2.13.5 SK Biopharmaceuticals Recent Developments and Future Plans

3 Market Competition, by Players

• 3.1 Global Psychiatric Medications Revenue and Share by Players (2018-2023)
• 3.2 Market Share Analysis (2022)
  • 3.2.1 Market Share of Psychiatric Medications by Company Revenue
  • 3.2.2 Top 3 Psychiatric Medications Players Market Share in 2022
  • 3.2.3 Top 6 Psychiatric Medications Players Market Share in 2022
• 3.3 Psychiatric Medications Market: Overall Company Footprint Analysis
  • 3.3.1 Psychiatric Medications Market: Region Footprint
  • 3.3.2 Psychiatric Medications Market: Company Product Type Footprint
  • 3.3.3 Psychiatric Medications Market: Company Product Application Footprint
• 3.4 New Market Entrants and Barriers to Market Entry
• 3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type

• 4.1 Global Psychiatric Medications Consumption Value and Market Share by Type (2018-2023)
• 4.2 Global Psychiatric Medications Market Forecast by Type (2024-2029)

5 Market Size Segment by Application

• 5.1 Global Psychiatric Medications Consumption Value Market Share by Application (2018-2023)
• 5.2 Global Psychiatric Medications Market Forecast by Application (2024-2029)

6 North America

• 6.1 North America Psychiatric Medications Consumption Value by Type (2018-2029)
• 6.2 North America Psychiatric Medications Consumption Value by Application (2018-2029)
• 6.3 North America Psychiatric Medications Market Size by Country
  • 6.3.1 North America Psychiatric Medications Consumption Value by Country (2018-2029)
  • 6.3.2 United States Psychiatric Medications Market Size and Forecast (2018-2029)
  • 6.3.3 Canada Psychiatric Medications Market Size and Forecast (2018-2029)
  • 6.3.4 Mexico Psychiatric Medications Market Size and Forecast (2018-2029)

7 Europe

• 7.1 Europe Psychiatric Medications Consumption Value by Type (2018-2029)
• 7.2 Europe Psychiatric Medications Consumption Value by Application (2018-2029)
• 7.3 Europe Psychiatric Medications Market Size by Country
  • 7.3.1 Europe Psychiatric Medications Consumption Value by Country (2018-2029)
  • 7.3.2 Germany Psychiatric Medications Market Size and Forecast (2018-2029)
  • 7.3.3 France Psychiatric Medications Market Size and Forecast (2018-2029)
  • 7.3.4 United Kingdom Psychiatric Medications Market Size and Forecast (2018-2029)
  • 7.3.5 Russia Psychiatric Medications Market Size and Forecast (2018-2029)
  • 7.3.6 Italy Psychiatric Medications Market Size and Forecast (2018-2029)

8 Asia-Pacific

• 8.1 Asia-Pacific Psychiatric Medications Consumption Value by Type (2018-2029)
• 8.2 Asia-Pacific Psychiatric Medications Consumption Value by Application (2018-2029)
• 8.3 Asia-Pacific Psychiatric Medications Market Size by Region
  • 8.3.1 Asia-Pacific Psychiatric Medications Consumption Value by Region (2018-2029)
  • 8.3.2 China Psychiatric Medications Market Size and Forecast (2018-2029)
  • 8.3.3 Japan Psychiatric Medications Market Size and Forecast (2018-2029)
  • 8.3.4 South Korea Psychiatric Medications Market Size and Forecast (2018-2029)
  • 8.3.5 India Psychiatric Medications Market Size and Forecast (2018-2029)
  • 8.3.6 Southeast Asia Psychiatric Medications Market Size and Forecast (2018-2029)
  • 8.3.7 Australia Psychiatric Medications Market Size and Forecast (2018-2029)

9 South America

• 9.1 South America Psychiatric Medications Consumption Value by Type (2018-2029)
• 9.2 South America Psychiatric Medications Consumption Value by Application (2018-2029)
• 9.3 South America Psychiatric Medications Market Size by Country
  • 9.3.1 South America Psychiatric Medications Consumption Value by Country (2018-2029)
  • 9.3.2 Brazil Psychiatric Medications Market Size and Forecast (2018-2029)
  • 9.3.3 Argentina Psychiatric Medications Market Size and Forecast (2018-2029)

10 Middle East & Africa

• 10.1 Middle East & Africa Psychiatric Medications Consumption Value by Type (2018-2029)
• 10.2 Middle East & Africa Psychiatric Medications Consumption Value by Application (2018-2029)
• 10.3 Middle East & Africa Psychiatric Medications Market Size by Country
  • 10.3.1 Middle East & Africa Psychiatric Medications Consumption Value by Country (2018-2029)
  • 10.3.2 Turkey Psychiatric Medications Market Size and Forecast (2018-2029)
  • 10.3.3 Saudi Arabia Psychiatric Medications Market Size and Forecast (2018-2029)
  • 10.3.4 UAE Psychiatric Medications Market Size and Forecast (2018-2029)

11 Market Dynamics

• 11.1 Psychiatric Medications Market Drivers
• 11.2 Psychiatric Medications Market Restraints
• 11.3 Psychiatric Medications Trends Analysis
• 11.4 Porters Five Forces Analysis
  • 11.4.1 Threat of New Entrants
  • 11.4.2 Bargaining Power of Suppliers
  • 11.4.3 Bargaining Power of Buyers
  • 11.4.4 Threat of Substitutes
  • 11.4.5 Competitive Rivalry
• 11.5 Influence of COVID-19 and Russia-Ukraine War
  • 11.5.1 Influence of COVID-19
  • 11.5.2 Influence of Russia-Ukraine War

12 Industry Chain Analysis

• 12.1 Psychiatric Medications Industry Chain
• 12.2 Psychiatric Medications Upstream Analysis
• 12.3 Psychiatric Medications Midstream Analysis
• 12.4 Psychiatric Medications Downstream Analysis

13 Research Findings and Conclusion

14 Appendix

• 14.1 Methodology
• 14.2 Research Process and Data Source